Cargando…
Management of Iron Overload in Beta-Thalassemia Patients: Clinical Practice Update Based on Case Series
Thalassemia syndromes are characterized by the inability to produce normal hemoglobin. Ineffective erythropoiesis and red cell transfusions are sources of excess iron that the human organism is unable to remove. Iron that is not saturated by transferrin is a toxic agent that, in transfusion-dependen...
Autores principales: | Pinto, Valeria Maria, Forni, Gian Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699680/ https://www.ncbi.nlm.nih.gov/pubmed/33233561 http://dx.doi.org/10.3390/ijms21228771 |
Ejemplares similares
-
How Early Can Myocardial Iron Overload Occur in Beta Thalassemia Major?
por: Yang, Gaohui, et al.
Publicado: (2014) -
Effect of iron overload on renal functions and oxidative stress in beta thalassemia patients
por: Rasool, Mahmood, et al.
Publicado: (2016) -
Brain iron content in systemic iron overload: A beta-thalassemia quantitative MRI study
por: Manara, Renzo, et al.
Publicado: (2019) -
Therapeutic Value of Combined Therapy with Deferasirox and Silymarin on Iron Overload in Children with Beta Thalassemia
por: Hagag, Adel A., et al.
Publicado: (2013) -
Estimation of iron overloads using oral exfoliative cytology in beta-thalassemia major patients
por: Leekha, Swati, et al.
Publicado: (2016)